Clinical Trials Browser

Adenosarcoma of the uterus, Sarcoma, Endometrial Stromal, Perivascular Epithelioid Cell Neoplasms

NCT05386108 2026-02-05

ELECTRA

Brain Diseases, Brain Neoplasms, Breast Diseases, Breast Neoplasms, Central Nervous System Diseases, Neoplasms, Neoplasms by Site, Central Nervous System Neoplasms

NCT07222215 2026-01-22

CAPELA

Phase 2 Recruiting

297 enrolled

Breast

Breast Neoplasms

NCT05963997 2026-01-16

SUMIT-ELA

Phase 1/2 Active not recruiting

49 enrolled

Breast

Breast Neoplasms

NCT03778931 2025-09-15

EMERALD

Phase 3 Completed

478 enrolled 16 charts 1 FDA

Breast

Breast Neoplasms

NCT05618613 2025-05-09

ELONA

Phase 1/2 Terminated

4 enrolled

Breast

Breast Neoplasms

NCT06126575 2024-11-19

A PK Study Testing Single Oral Dose of Elacestrant in Subjects With Normal or Severely Impaired Hepatic Function

Phase 1 Completed

16 enrolled

Breast

Breast Neoplasms

NCT02650817 2022-08-18

Phase IB Study to Evaluate RAD1901 on the Availability of Estrogen Receptor Binding Sites in Metastatic Breast Cancer

Phase 1 Completed

16 enrolled

Breast

Breast Neoplasms

Clinical Trials

Ph 2 Elacestrant in ER Positive Uterine Sarcomas

ELECTRA

CAPELA

SUMIT-ELA

EMERALD

ELONA

A PK Study Testing Single Oral Dose of Elacestrant in Subjects With Normal or Severely Impaired Hepatic Function

Phase IB Study to Evaluate RAD1901 on the Availability of Estrogen Receptor Binding Sites in Metastatic Breast Cancer